
BIO names longtime Amicus head John Crowley as its new CEO
The Biotech Innovation Organization on Tuesday named Amicus Therapeutics co-founder and longtime leader John Crowley as its new CEO, taking over a spot interim chief Rachel King has held for the past 14 months. BIO’s decision to name Crowley, who will assume the role effective March 4, as permanent CEO comes just over a year…